Chinese medicine combined with conventional treatment significantly improved clinical efficacy, increased viral nucleic acid negative conversion rate, prominently reduced pulmonary inflammation, and improved host immune function.
A total of 7 valid studies involving 681 patients were included. The meta-analysis exhibited in comparison to conventional treatment, Chinese medicine combined with conventional treatment significantly improved clinical efficacy, and significantly increased viral nucleic acid negative conversion rate. Chinese medicine also prominently reduced pulmonary inflammation, and improved host immune function. Meanwhile, Chinese medicine did not increase the incidence of adverse reactions.
According to the allocated data, Chinese medicine has demonstrated clinical efficacy and safety on COVID-19 pneumonia, which need to be confirmed by high quality, multiple-center, large sample randomized controlled trials.
